Volkan Eren is now vice president of sales and business development, while Catherine Kwik-Uribe is vice president of scientific and regulatory affairs.
Everwell Health (Lake Forest IL), which in 2021 acquired ingredient supplier Nutrition21 (Harrison, NY), appointed two new key executives from the natural products industry. Volkan Eren is now vice president of sales and business development, while Catherine Kwik-Uribe is vice president of scientific and regulatory affairs.
Eren hails from ingredient companies like Enzymotec, Frutarom, and IFF. As head of Everwell’s sales team, he will lead commercial strategy and business expansion. Kwik-Uribe comes from a successful career at Mars Inc. where she served as vice president, scientific and regulatory affairs, applied science and nutrition, for Mars Edge. She now heads up the clinical research needs, new product claims, and regulatory approval activities at Everwell.
The company says that both Eren and Kwik-Uribe “also bring M&A experience that will be important as Everwell Health invests to expand the platform.”
In a press release, Steve Rosenman, Everwell Health’s CEO, stated, “These new leaders complement our existing team at Nutrition21. Their experience and success, both at nimble, high-growth companies and at highly professional, scaled global enterprises, will support Everwell Health’s dual growth strategy of optimizing organic opportunities at Nutrition21 while aggressively developing strategic partnerships and pursuing external business development.”